TheraRadar
Data updated: Jul 17, 2026

RYZOLT (tramadol hydrochloride) · PURDUE PHARMA

Pain Approved 2008-12-30

RYZOLT is FDA-approved to treat 1 condition (same as TRAMADOL HYDROCHLORIDE).

1
Indication
--
Phase 3 Trials
17
Years on Market

Details

Status
Discontinued
First Approved
2008-12-30
Routes
ORAL
Dosage Forms
TABLET, EXTENDED RELEASE

Companies

Active Ingredient: TRAMADOL HYDROCHLORIDE

RYZOLT Approval History

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
3 FDA actions from 2008 to 2008
Dec 2008 ORIGINAL
Update · Type 5 - New Formulation or New Manufacturer

What RYZOLT Treats

1 indications

RYZOLT is approved for 1 conditions since its original approval in 2008. These indications span multiple therapeutic areas including oncology, immunology, and more.

Same approved indications as TRAMADOL HYDROCHLORIDE (same active ingredient).

Source: FDA Label
📋

Clinical Trial Registry

12 trials
Trial Sponsor ID Phase Status Title
NCT07440069 TRAMPA PO-UNAH-49-7-2026 Ph 4 recruiting Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor
NCT04991493 QPOST Ph 4 recruiting Effect of Tramadol on Postoperative Sore Throat After General Anesthesia
NCT05125978 CANADÁ EMS1120 - CANADÁ Ph 2 withdrawn Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain
NCT05390905 HSK21542-303 Ph 3 completed A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment
NCT04613830 515 Ph 3 completed Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients
NCT03775629 CG100650-1-01 Ph 1 completed Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers
NCT03477851 TramIsch WNOZA/1/2017 Ph 4 completed Tramadol Simultaneously With Sciatic Nerve Block for Calcaneus Fracture Osteosynthesis
NCT04178109 17200 Ph 2 completed Oral Use of Dexketoprofen/Tramadol for Acute Postoperative Pain in Total Hip Replacement With a Direct Anterior Approach.
NCT00737048 results posted CR015109 JNS013-JPN-03 Ph 3 completed A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction Pain
NCT01307020 DEX-TRA 02 results posted DEX-TRA 02 2010-022798-32 Ph 2 completed Analgesic Effect of Different Combinations of Dexketoprofen Trometamol With Tramadol Hydrochloride in a Model of Moderate to Severe Pain
NCT00766675 results posted CR015319 TRAMMAPPAI4033 Ph 4 completed An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain
NCT00983736 BVF-324-302 Ph 3 terminated Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

RYZOLT FDA Label Details

Indications & Usage

FDA Label (PDF)

RYZOLT is FDA-approved to treat 1 condition — same approved indications as TRAMADOL HYDROCHLORIDE.

Track RYZOLT with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.